Prenatal exposure to buprenorphine or methadone and adverse neurodevelopmental outcomes: population based cohort study
Sabine Friedrich, Krista F Huybrechts, Loreen Straub, Sonia Hernandez-Diaz, Yanmin Zhu, Georg Hahn, Helen Mogun, Hendrée E Jones, Hilary S Connery, Jonathan M Davis, Kathryn J Gray, Barry Lester, Mishka Terplan, Brian T Bateman · 2026
Read Prenatal exposure to buprenorphine or methadone and adverse neurodevelopmental outcomes: population based cohort study by Sabine Friedrich, Krista F Huybrechts, Loreen Straub, Sonia Hernandez-Diaz, Yanmin Zhu, Georg Hahn, Helen Mogun, Hendrée E Jones, Hilary S Connery, Jonathan M Davis, Kathryn J Gray, Barry Lester, Mishka Terplan, Brian T Bateman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13081224.txt.
Description
ObjectiveTo compare the incidence of neurodevelopmental disorders among children with prenatal exposure to buprenorphine versus methadone.DesignPopulation based cohort study.SettingUS nationwide Medicaid data on >2.5 million live births from 2000 to 2018.Participants18 612 pregnancies exposed to buprenorphine or methadone, of which 587 were excluded from the analysis owing to exposure to the comparator drug.
Catalog record
| CREATOR | Sabine Friedrich, Krista F Huybrechts, Loreen Straub, Sonia Hernandez-Diaz, Yanmin Zhu, Georg Hahn, Helen Mogun, Hendrée E Jones, Hilary S Connery, Jonathan M Davis, Kathryn J Gray, Barry Lester, Mishka Terplan, Brian T Bateman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |